Opendata, web and dolomites

PIBD-SETQuality SIGNED

Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality improvement of care

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PIBD-SETQuality project word cloud

Explore the words cloud of the PIBD-SETQuality project. It provides you a very rough idea of what is the project "PIBD-SETQuality" about.

exposing    signals    analyze    clinical    umbrella    network    severe    feasible    medical    balance    randomized    adalimumab    inflammatory    infections    azathioprine    international    independent    therapeutic    individual    performance    world    adverse    immunomodulators    stratification    decades    treatment    urgent    inception    cohort    algorithms    pibd    groups    bowel    effectiveness    requiring    strategies    aim    validate    therapy    optimization    accessible    forms    events    correlate    malignancies    thereby    trial       attain    paediatric    basis    reflects    personalized    relapsing    complications    onset    minimizing    life    adult    risk    methotrexate    optimal    safety    predictors    multicenter    aggressive    generation    validation    complicated    rct    algorithm    registry    uncontrolled    children    first    progression    reducing    net    translate    stratified    prospective    longterm    diseases    medicine    vx    designed    risks    incidence    dramatically    serious    disease    ibd   

Project "PIBD-SETQuality" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE DE PARIS 

There are not information about this coordinator. Please contact Fabio for more information, thanks.

 Coordinator Country France [FR]
 Project website http://sites-e-play.parisdescartes.fr/pibd/
 Total cost 5˙996˙000 €
 EC max contribution 5˙996˙000 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-PHC-2015-two-stage
 Funding Scheme RIA
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2021-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE DE PARIS FR (PARIS) coordinator 580˙000.00
2    UNIVERSITE PARIS DESCARTES FR (PARIS CEDEX 06) coordinator 0.00
3    PEDIATRIC INFLAMATORY BOWEL DISEASES NETWORK PIBD-NET FR (PARIS) participant 2˙539˙882.00
4    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 682˙980.00
5    GREATER GLASGOW HEALTH BOARD UK (GLASGOW) participant 431˙459.00
6    SHAARE ZEDEK MEDICAL CENTER IL (JERUSALEM) participant 427˙338.00
7    QUEEN MARY UNIVERSITY OF LONDON UK (LONDON) participant 331˙750.00
8    VRIJE UNIVERSITEIT BRUSSEL BE (BRUSSEL) participant 259˙720.00
9    UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA IT (ROMA) participant 192˙861.00
10    THE FOUNDATION FOR MEDICAL RESEARCH AND DEVELOPMENT OF INFRASTRUCTURES AND HEALTHCARE SERVICES BY THE E WOLSFON MEDICAL CENTER IL (HOLON) participant 176˙611.00
11    VIB BE (ZWIJNAARDE - GENT) participant 150˙000.00
12    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 120˙895.00
13    AIMES GRID SERVICES COMMUNITY INTEREST COMPANY UK (LIVERPOOL) participant 51˙375.00
14    DEUTSCHE MORBUS CROHN/COLITIS ULCEROSA VEREINIGUNG BUNDESVERBAND FUR CHRONISCH ENTZUNDLICHE ERKRANKUNGENDES VERDAUUNGSTRAKTES (DCCV) EV DE (BERLIN) participant 33˙750.00
15    AIMES MANAGEMENT SERVICES LIMITED UK (LIVERPOOL) participant 17˙375.00

Map

 Project objective

'The incidence of paediatric onset Inflammatory Bowel Diseases (PIBD) has risen dramatically in recent decades. Compared to adult forms, PIBD reflects a more severe disease, more often requiring aggressive treatment with immunomodulators, and thereby exposing children to a life-long risk of serious disease and treatment-related adverse events, such as infections and malignancies. Therefore, there is an urgent need to develop strategies which balance, on an individual basis, therapeutic effectiveness with risks of treatment. The overall goal of this proposal is to develop and validate a treatment algorithm for PIBD based on high or low risk predictors for early complicated or relapsing disease. This will improve effectiveness, while reducing treatment related risks and life-long complications due to uncontrolled disease progression.

To attain this goal 3 specific aims are proposed under the umbrella of an international network, the 'PIBD-net': 1) Development of an accessible and feasible risk-stratified treatment algorithm for new onset paediatric IBD on an existing inception cohort and validation in an independent cohort 2) Generation of a prospective large longterm real world inception cohort in a registry designed to analyze effectiveness and safety signals and correlate them to individual risk factors 3) Design and performance of a risk algorithm-based prospective large-scale multicenter randomized clinical trial (RCT) (stratification into high or low risk groups based on specific aim#1) in order to provide optimal personalized therapy : low risk azathioprine vx. methotrexate, high risk : methotrexate vx. adalimumab This project will translate into the first risk-stratified PIBD treatment algorithms allowing optimization of medical therapy while minimizing treatment-related risk (personalized medicine).

'

 Deliverables

List of deliverables.
Clinical Research Tool Demonstration (Demonstrator) Documents, reports 2020-02-24 13:41:24
Internal annual report related to WPs Documents, reports 2020-02-24 13:41:24
Annual summary of incidence and prevalence of rare complications Documents, reports 2020-02-24 13:41:24
1st patient recruited Documents, reports 2020-02-24 13:41:23
Implementation of the project website Documents, reports 2020-02-24 13:41:23
“Kick-off meetings and annual meetings” Documents, reports 2020-02-24 13:41:23

Take a look to the deliverables list in detail:  detailed list of PIBD-SETQuality deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 P Kemos, M Aardoom, F Ruemmele, L de Ridder, N Croft
P785 Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications
published pages: S508-S508, ISSN: 1873-9946, DOI: 10.1093/ecco-jcc/jjx180.912
Journal of Crohn\'s and Colitis 12/supplement_1 2020-02-24
2018 M Aardoom, P Kemos, F Ruemmele, N Croft, L de Ridder
P584 Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet
published pages: S403-S404, ISSN: 1873-9946, DOI: 10.1093/ecco-jcc/jjx180.711
Journal of Crohn\'s and Colitis 12/supplement_1 2020-02-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PIBD-SETQUALITY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PIBD-SETQUALITY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More